United States · FDA National Drug Code directory

Par Health USA, LLC

Labeler · 216 source records

The organisation role is retained from the source. Companies with similar names in other sources are not automatically merged.

United States · Source reference 0254-2005_865f5a6c-7cbc-48b6-92c7-55b4e50c8681

Chlorzoxazone

TABLET / Par Health USA, LLC

United States · Source reference 0254-2053_865f5a6c-7cbc-48b6-92c7-55b4e50c8681

Chlorzoxazone

TABLET / Par Health USA, LLC

United States · Source reference 49884-465_587586f5-0b75-4dc8-b78d-477a66e0cb30

Cholestyramine

POWDER, FOR SUSPENSION / Par Health USA, LLC

United States · Source reference 49884-466_587586f5-0b75-4dc8-b78d-477a66e0cb30

Cholestyramine

POWDER, FOR SUSPENSION / Par Health USA, LLC

United States · Source reference 49884-306_cb847105-dbbe-4e7a-ab2b-ad0731638ce6

Clonazepam

TABLET, ORALLY DISINTEGRATING / Par Health USA, LLC

United States · Source reference 49884-307_cb847105-dbbe-4e7a-ab2b-ad0731638ce6

Clonazepam

TABLET, ORALLY DISINTEGRATING / Par Health USA, LLC

United States · Source reference 49884-308_cb847105-dbbe-4e7a-ab2b-ad0731638ce6

Clonazepam

TABLET, ORALLY DISINTEGRATING / Par Health USA, LLC

United States · Source reference 49884-309_cb847105-dbbe-4e7a-ab2b-ad0731638ce6

Clonazepam

TABLET, ORALLY DISINTEGRATING / Par Health USA, LLC

United States · Source reference 49884-310_cb847105-dbbe-4e7a-ab2b-ad0731638ce6

Clonazepam

TABLET, ORALLY DISINTEGRATING / Par Health USA, LLC

United States · Source reference 0254-0460_3921574e-5169-46b3-9236-d23609465864

Colchicine

CAPSULE / Par Health USA, LLC

United States · Source reference 49884-171_2468e21c-34c3-4980-a6da-0586e6b1c144

Colchicine

TABLET, FILM COATED / Par Health USA, LLC

United States · Source reference 42023-107_2a986c38-f75d-48e0-a567-a4b8d4644347

Coly-Mycin M

INJECTION / Par Health USA, LLC

United States · Source reference 42023-244_4449220f-2186-4b68-838b-1f023e7e0772

DOXYCYCLINE

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Par Health USA, LLC

United States · Source reference 42023-123_dd4a56ce-80e3-4794-94a8-cb2b14695b89

Dantrium

INJECTION / Par Health USA, LLC

United States · Source reference 42023-124_4bcdd632-5be8-4750-a3b6-59a2b6d8f130

Dantrium

CAPSULE / Par Health USA, LLC

United States · Source reference 42023-295_f210e0b8-5a7e-4ba9-b4ab-ad86a4ec8bf4

Daptomycin

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Par Health USA, LLC

United States · Source reference 42023-110_58569bae-90e9-492c-a026-9a7b8797b3b4

Delestrogen

INJECTION / Par Health USA, LLC

United States · Source reference 42023-111_58569bae-90e9-492c-a026-9a7b8797b3b4

Delestrogen

INJECTION / Par Health USA, LLC

United States · Source reference 49884-147_d173ea78-6398-49ea-8742-5d4093250cfd

Dexlansoprazole

CAPSULE, DELAYED RELEASE / Par Health USA, LLC

United States · Source reference 49884-148_d173ea78-6398-49ea-8742-5d4093250cfd

Dexlansoprazole

CAPSULE, DELAYED RELEASE / Par Health USA, LLC

United States · Source reference 42023-146_54174211-6684-4fb9-a605-be12b94e2948

Dexmedetomidine Hydrochloride

INJECTION, SOLUTION, CONCENTRATE / Par Health USA, LLC

United States · Source reference 42023-186_54174211-6684-4fb9-a605-be12b94e2948

Dexmedetomidine Hydrochloride

INJECTION, SOLUTION / Par Health USA, LLC

United States · Source reference 42023-187_54174211-6684-4fb9-a605-be12b94e2948